LOWER: Lomitapide Observational Worldwide Evaluation Registry
Study Identifier:
AEGR-733-025
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Study Contact Information:
Recruiting
Study Details
Medical Condition
- Homozygous Familial Hypercholesterolaemia (HoFH)
Study Drug
- Drug: Lomitapide
Date
Mar 2014 - Mar 2028
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: N/A+ years
Requirements Information
Healthy Volunteers
No
Protocol Summary
This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.
Study Locations
Location
Status
Location
Brookwood Baptist Medical Center
Birmingham, Alabama, United States, 35209
Status
Recruiting
Location
Springhill Physician Practices
Mobile, Alabama, United States, 36608
Status
Terminated
Location
Northern Arizona Healthcare
Cottonwood, Arizona, United States, 86326
Status
Recruiting
Location
One Medical
Gilbert, Arizona, United States, 85296
Status
Withdrawn
Location
Scottsdale Family Health
Phoenix, Arizona, United States, 85018
Status
Recruiting
Location
Pima Heart
Tucson, Arizona, United States, 85718
Status
Terminated